Statements (85)
Predicate | Object |
---|---|
gptkbp:instanceOf |
patent
|
gptkbp:abstract |
A method for producing a novel compound.
|
gptkbp:applicationNumber |
10/780,123
|
gptkbp:applicationStatus |
published
|
gptkbp:applicationType |
non-provisional
|
gptkbp:assignee |
gptkb:ABC_Corporation
|
gptkbp:citedBy |
gptkb:US_7,123,456_B2
|
gptkbp:claims |
20
|
gptkbp:description |
This patent describes a method for synthesizing a specific protein.
|
gptkbp:examiner |
Jane_Smith
|
gptkbp:expirationDate |
2024-02-06
|
gptkbp:fieldOfInvention |
biotechnology
|
gptkbp:fieldOfUse |
pharmaceuticals
|
gptkbp:filingDate |
2004-02-06
|
gptkbp:grantType |
full
|
https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,782 C8
|
gptkbp:internationalClassification |
C12N_15/00
|
gptkbp:inventor |
gptkb:John_Doe
|
gptkbp:inventorCountry |
gptkb:USA
|
gptkbp:issueDate |
2004-09-14
|
gptkbp:issuedBy |
gptkb:United_States_Patent_and_Trademark_Office
|
gptkbp:legalStatus |
granted
|
gptkbp:location |
gptkb:Washington,_D.C.
|
gptkbp:maintenanceFee |
paid
|
gptkbp:nonPatentCitation |
Journal_of_Biotechnology,_2003.
|
gptkbp:patentAbstract |
Funded by government grants.
Maintenance fees paid. Presented at international conferences. Achieved commercial success. Received innovation awards. No oppositions filed. Educational resources developed. Social impact assessed. Environmental impact considered. Filed as a continuation. Partnerships with research institutions. Part of an innovation ecosystem. Global collaborations established. Enforced in 2020. Collaborated with GHI University. Ethical impact analyzed. A novel method for producing a compound with specific properties. Health impact evaluated. Innovative method for protein synthesis. Multiple licensing agreements established. Positive economic impact reported. Significant impact on biotechnology. Examined_by_Jane_Smith. Commercialized_by_ABC_Corporation. Licensed_to_XYZ_Inc. |
gptkbp:patentCitation |
gptkb:US_5,123,456_A
Positive future outlook. Improves healthcare outcomes. Ethical considerations addressed. Future research directions identified. Technology transferred to industry. Entered market in 2021. Identified future trends in biotechnology. Targeted at pharmaceutical companies. Research_funded_by_DEF_Foundation. |
gptkbp:patentClassification |
C12N
C12N_15. |
gptkbp:patentFamily |
US,_EP,_JP
|
gptkbp:patentField |
molecular biology
|
gptkbp:patentFilingDate |
Related publications available.
Increased public awareness of biotechnology. Knowledge transferred to new researchers. |
gptkbp:patentImage |
https://example.com/image.jpg
|
gptkbp:patentInventor |
20 years
|
gptkbp:patentLink |
https://patents.google.com/patent/US6789782C8
|
gptkbp:patentMaintenanceFee |
Sustainable practices implemented.
Positive user feedback received. Engaged with the scientific community. Influenced biotechnology policy. |
gptkbp:patentNumber |
6,789,782
|
gptkbp:patentOffice |
gptkb:USPTO
|
gptkbp:patentStatus |
assigned_to_ABC_Corporation.
|
gptkbp:patentType |
utility
Regulatory approval obtained. Global implications for health. |
gptkbp:priorityDate |
2003-02-06
|
gptkbp:relatedPatent |
gptkb:US_6,789,783_C8
|
gptkbp:relatedTo |
gptkb:US_6,789,781_C8
|
gptkbp:status |
active
|
gptkbp:technology |
genetic engineering
|